Hostname: page-component-68c7f8b79f-xmwfq Total loading time: 0 Render date: 2025-12-25T15:08:42.040Z Has data issue: false hasContentIssue false

A successfully shortened outbreak of vancomycin-resistant Enterococcus faecium in a secondary care hospital in Sweden

Published online by Cambridge University Press:  19 December 2025

Maria Gideskog*
Affiliation:
Department of Communicable Disease and Infection Control, and Department of Biomedical and Clinical Sciences, Linköping University, Linköping, Sweden
Jenny Welander
Affiliation:
Department of Clinical Microbiology, and Department of Biomedical and Clinical Sciences, Linköping University, Linköping, Sweden
Anita Hällgren
Affiliation:
Department of Infectious Diseases in Östergötland, and Department of Biomedical and Clinical Sciences, Linköping University, Linköping, Sweden
Lena Serrander
Affiliation:
Department of Clinical Microbiology, and Department of Biomedical and Clinical Sciences, Linköping University, Linköping, Sweden
*
Corresponding author: Maria Gideskog; Email: maria.gideskog@regionostergotland.se

Abstract

Background:

Outbreaks of vancomycin-resistant Enterococcus faecium (VRE) are often difficult to contain. In this study, we developed and implemented a set of control measures, which resulted in a relatively limited outbreak in a secondary care hospital in Sweden.

Methods:

VRE screening was performed by rapid polymerase chain reaction (PCR) on fecal swabs, reported within 1–3 h. Vancomycin-resistant isolates PCR-positive for the vanA/vanB gene were further analyzed with whole-genome sequencing (WGS). Cleaning efficiency was evaluated directly after cleaning by using adenosine triphosphate (ATP) swabs, detecting organic live material. The hospital management appointed a task force consisting of experts in infectious diseases, microbiology, hospital hygiene, cleaning and representatives of the affected unit.

Results:

A total of 22 VRE-positive patients were identified, of which 12 isolates belonged to the same clone (ST 203) in a surgical ward. VRE screening by PCR shortened the turnaround time. The combination of rapid PCR and WGS could rule in or out cases from the outbreak within less than a week. The new cleaning routine indicated that 3 approved quality-controlled discharge cleanings were required to reduce VRE acquisition. The fast lane to decision-making on control measures resulted in rapid introduction of the above routines.

Conclusions:

With prompt infection control measures, the VRE outbreak was contained after 4 months. To prevent further outbreaks of VRE, active rapid screening, improved cleaning, and restriction of multiple-bed rooms are efficient measures to implement.

Information

Type
Original Article
Creative Commons
Creative Common License - CCCreative Common License - BY
This is an Open Access article, distributed under the terms of the Creative Commons Attribution licence (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted re-use, distribution and reproduction, provided the original article is properly cited.
Copyright
© The Author(s), 2025. Published by Cambridge University Press on behalf of The Society for Healthcare Epidemiology of America

Background

Vancomycin-resistant Enterococcus faecium (VRE) has established itself as an important nosocomial pathogen. Infections caused by VRE include infective endocarditis, catheter-associated bloodstream infections, urinary tract infections, and bacteremia. Patients at risk for infection include those with critical illnesses in intensive care units, severe underlying disease, or a weakened immune system. Reference Reyes, Bardossy and Zervos1,Reference Levitus, Rewane and Perera2 VRE are hardy organisms with the ability to survive for long periods in adverse environmental conditions. Reference Fiore, Van Tyne and Gilmore3

Reducing VRE acquisition in healthcare environments require multiple strategies, including antimicrobial stewardship to reduce selection of VRE in colonized patients, appropriate infection control measures such as strict adherence to basic hygiene routines and adequate cleaning to reduce transmission, and reliable sensitive laboratory methods for detection of VRE in a timely manner. Reference Reyes, Bardossy and Zervos1,Reference Faron, Ledeboer and Buchan4Reference Collins, Kollmeyer and Scheidel6 A previous study highlights the importance of identifying the source of VRE acquisition in the implementation of control measures, that is determining whether it is assumed to be due to cross-transmission or background acquisition. Reference Cheah, Cheng, Spelman, Nation, Kong and McBryde7 Polymerase chain reaction (PCR)-based screening has a high diagnostic accuracy and is, compared to culture-based screening, more timesaving in providing results. While culture turnaround time usually is several days, PCR results can be reported within just a few hours. Reference Holzknecht, Hansen, Nielsen, Kailow and Jarlov8

The prevalence of VRE in Sweden remained low until 2007, when a large outbreak involving 3 hospitals in separate counties occurred. Reference Soderblom, Aspevall and Erntell9 Since then, VRE outbreaks have been reported in several counties in Sweden. However, only sporadic, epidemiologically unrelated cases of VRE have been identified from clinical samples in Östergötland County. The aim of this study was to investigate a sudden increase in VRE cases in 2021 among patients admitted to a surgical unit at Vrinnevi Hospital, Norrköping, Östergötland County, Sweden, and to describe the measures implemented to contain the outbreak.

Methods

Settings

Vrinnevi Hospital is a secondary care hospital with 180 beds and a catchment population of approximately 200,000 inhabitants. The Surgical Unit at Vrinnevi Hospital comprised 2 wards at the time: ward 11, focusing on colorectal and acute general surgery, and ward 12, specializing in upper abdominal surgery and urology. Each ward offered 28 beds in 14 rooms (8 single-bed, 6 multi-bed: 4 × 4-bed and 2 × 2-bed rooms), with shared health care workers and medical supply storage.

The hospital’s infection prevention policy recommended single-bed rooms for VRE-positive patients, with VRE carriage consistently documented in patient records. However, no standardized screening protocol was in place prior to the outbreak, and ward design occasionally limited the availability of single rooms, as was the case in the Surgical Unit. Prior to the outbreak, adherence to basic hygiene routines ranged around 80%–90%, according to observation-based compliance audits.

An antibiotic audit and feedback program implemented at the Surgical Unit prior to the outbreak had reduced carbapenem and third-generation cephalosporin use in favor of piperacillin/tazobactam, which remained stable at the time of the outbreak. To further assess prescribing patterns, antibiotic prescriptions during the 3 months preceding the outbreak were reviewed. In addition, a meeting with the urological surgeons was held to discuss and implement updated antibiotic stewardship recommendations.

Screening for VRE in patient and environmental samples

Patient and environmental samples were collected with ESwabs (Copan Diagnostics Inc. Murrieta, CA, USA). Screening for the vanA/vanB gene was performed directly from ESwabs using the GeneXpert system and the Xpert vanA/vanB kit (Cepheid, Sunnyvale, CA, USA), following the manufacturer’s instructions. Fecal samples were collected from patients who had either been transferred from the Surgical Unit at Vrinnevi Hospital to another unit or readmitted to the hospital after previously receiving care at the Surgical Unit.

As a complement to the individual rapid screening, weekly batched screening was performed of all patients at the Surgical Unit by direct DNA extraction from ESwabs using the STARMag Viral DNA/RNA 200C kit on the Seegene STARlet IVD system, followed by real-time PCR with the Allplex™ Entero-DR Assay (Seegene Inc., Seoul, South Korea) on the CFX96™ real-time PCR detection system (Bio-Rad, Hercules, CA, USA). All methods were carried out in accordance with the manufacturer’s instructions. The same screening approach was applied to units with patient exchange with the Surgical Unit. Samples testing positive for van genes were subsequently cultured for confirmation, as described below. The screening protocol included continued sampling until 1 month had passed without detection of new VRE cases before declaring the outbreak contained. An outbreak was defined as the occurrence of more than 2 epidemiologically related cases.

Environmental samples were inoculated into VRE broth supplemented with vancomycin (0.75 mg/L, Sigma-Aldrich, St. Louis, MO, USA) and aztreonam (10 mg/L, MP Biomedicals, Illkirch-Graffenstaden, France) overnight and thereafter onto VRE Chromagar plates supplemented with chloramphenicol and dipotassium telluride (CHROMagar, Paris, France). The plates were incubated at 35°C for 48 h. Bacteria were identified to the species level with a MALDI Biotyper 3.0 (Bruker Corporation, Karlsruhe, Germany). E. faecium isolates with resistance to vancomycin were subjected to GeneXpert for verification of the vanA or vanB gene.

The preliminary reporting times for each method were as follows: 1–3 h for GeneXpert, 1 day for Seegene, and the final report for all samples was completed within 3 days.

WGS

All VRE isolates from patients and the environment were subjected to whole-genome sequencing (WGS). DNA was prepared from 10 µL of each isolate using an EZ1 DNA Tissue Kit (Qiagen, Germantown, MD, USA) with an included preheating step at 95°C and shaking at 350 rpm. Twenty nanograms of DNA was used for library preparation with a QIAseq FX DNA Library Kit (Qiagen, Germantown, MD, USA) with 8 min of fragmentation time. DNA libraries were sequenced on the MiSeq platform (Illumina, San Diego, CA, USA) with 2 × 300 bp paired-end reads, and an average sequencing depth of 210x was achieved for the samples.

Data analysis was performed in CLC Genomics Workbench v. 10.1.1 with the Microbial Genomics Module v. 2.5.1 (Qiagen, Germantown, MD, USA). Multilocus sequence typing (MLST) analysis was performed using the PubMLST (pubmlst.org) Reference Jolley, Bray and Maiden10 scheme for Enterococcus faecium. Reference Homan, Tribe and Poznanski11 Read mapping and variant calling were performed against the E. faecium reference genome with NCBI accession number NC_021994, with the following thresholds to call a variant: depth of coverage ≥ 20, frequency ≥ 90 % and Phred score ≥ 20. A quality filter was then applied that retained variants with a sequencing depth of ≥ 20x in all samples and a distance ≥ 10 bp to the next variant, and the resulting variants were used to create a single nucleotide polymorphism (SNP) tree and calculate genetic distances between samples. Previous studies suggest that isolates of E. faecium with a distance of ≤16 SNPs are likely to belong to the same clone. Reference Schurch, Arredondo-Alonso, Willems and Goering12

Cleaning and ATP measurements

Initially, rooms that had been occupied by confirmed VRE-positive patients were discharge cleaned once using Virkon™ (1%) and an alcohol-based disinfectant containing a surfactant. To assess environmental contamination and cleaning efficacy, samples were collected from high-touch surfaces in ward 12 previously occupied by VRE-positive patients. Since environmental cultures remained positive, triggering new episodes of VRE transmission, the discharge cleaning, including medical devises, was intensified to 3 times followed by visual hygiene observation and an approved quality control in terms of adenosine triphosphate (ATP) measurement to detect organic live material according to the manufacturer’s instructions (Neogen, Lansing, MI, USA). Cleaning followed routine procedures, with all surfaces cleaned, not only contaminated ones. Twenty locations in each patient room, including the bathroom, were subjects for ATP measurement, that is a total of 60 locations were measured in each discharge-cleaned patient room. All additional patient rooms at the Surgical Unit (non-VRE) were discharge-cleaned once with a subsequent approved quality control. Even the daily cleaning was quality-controlled, and disinfection of general surfaces was extended. During this process, the outbreak task force actively ensured that cleaning products were reviewed for efficacy, proper contact times were adhered to, cleaning workflows were observed, and responsibilities for cleaning were clearly defined. In connection with the intensified cleaning routine, the cleaning organization temporarily took over cleaning of patient rooms, including the daily cleaning of surfaces close to the patient, from healthcare workers for the remainder of the outbreak.

Results

Outbreak overview

In April 2021, a VRE-positive patient (index case), identified from a clinical sample, was re-admitted and placed in a single-bed room (room 14) in ward 12 at the Surgical Unit at Vrinnevi Hospital. The patient had been admitted to the ward on several previous occasions and placed in different single- and 4-bed rooms. A few months earlier, VRE was transmitted from the index case to another patient while placed in different rooms in ward 12. The transmitted E. faecium strain carried the vanA gene. Three additional VRE cases were identified through clinical cultures within a week of the index case’s re-admission to ward 12 (Figure 1). These patients were placed in 2 different 4-bed rooms with a shared bathroom in ward 12, including room 9, which had previously been occupied by the index case in the same bed space. To quickly and effectively minimize the extent of the VRE outbreak, the hospital management appointed a task force with experts in infectious diseases, microbiology, hospital hygiene, cleaning and representatives of the affected unit that had weekly meetings to discuss the current situation and operatively handle the outbreak.

Figure 1. Prevalence of patients positive for vancomycin-resistant enterococcus faecium (VRE) at Vrinnevi Hospital, Norrköping, Sweden, 2015—August 2021. Bars indicate the total number of VRE-positive cases identified each year. Outbreak-associated cases (ST 203) and unrelated cases are shown in distinct colors. Infection control measures implemented during the outbreak are indicated on the time line.

Subsequent screening for VRE was initiated as described above. Cases were defined as patients colonized with VRE, with the same van gene as the index case. An additional inclusion criterion was that there had to be a connection in time and space with the index case or another VRE-positive patient involved in the outbreak. Approximately 800 patients were screened for VRE during the screening period, which lasted from the end of April until the end of August 2021. The last VRE case occurred in July, and after 1 month without new cases, the outbreak was declared contained. Eight more cases were reported in ward 12 until the end of May. Additional VRE cases were reported at the Geriatric Unit (n = 2), the Emergency Unit (n = 2), ward 11 at the Surgical Unit (n = 1), the Cardiology Unit (n = 1), and the Infectious Diseases Unit (n = 1) at Vrinnevi Hospital, and 1 case was reported in a senior center in Norrköping. Another case was admitted to the Haematology Unit at Linköping University Hospital. The majority had previously received multiple antibiotic treatments, as documented in the medical record.

Hygiene observations by the Department of Communicable Disease and Infection Control revealed several deficiencies at the Surgical Unit. These were promptly addressed through control measures, including education and review of proper procedures to improve compliance with basic hygiene and cleaning routines, replacement of furniture and equipment that were impossible to disinfect, and clearing surfaces to enable effective disinfection. Patient-dedicated equipment was allocated. An admission stop and contact isolation were introduced in ward 12, with all multiple-bed rooms converted to single-bed rooms. Adherence to basic hygiene routines was observed to improve by the later stages of the outbreak and afterward, reaching consistently high levels of around 90%.

The review of antibiotic prescriptions from the 3 months preceding the outbreak showed that piperacillin/tazobactam accounted for over 50% of all prescriptions, while oral cephalosporins and ciprofloxacin dominated the remaining use. Updated antibiotic stewardship recommendations were subsequently implemented.

Beyond clinical and organizational measures, the outbreak also had substantial economic consequences. The estimated cost of the outbreak response was approximately 2.6 million SEK.

WGS results

Three outbreak clusters and 1 unique clone were recognized with MLST and whole genome-wide phylogenetic analysis (Figure 2). The larger cluster consisted of 22 isolates (69%) with a difference of 0–4 SNPs and belonged to the ST 203 clone. Included in this cluster were 12 VRE cases reported in ward 12 and all 10 VRE-positive environmental samples. Of these patients, 83% had been accommodated in the same 4-bed room (room 9) at some time during their admission (Figure 3). In the second cluster, 7 isolates (22%) with a difference of 0–4 SNPs and that belonged to ST 1839 were included. Among these isolates were 2 VRE cases reported in the Geriatric Unit, 2 in the Emergency Unit, 1 in ward 12, 1 in the Cardiology Unit, and 1 in a senior center in Norrköping. The third cluster consisted of 2 isolates (6%) of ST 80 with a difference of 5 SNPs from a patient in the Emergency Unit and another patient admitted to ward 11 at the Surgical Unit at Vrinnevi Hospital. The unique clone (ST 612) belonged to a patient admitted to the Haematology Unit at Linköping University Hospital (3%).

Figure 2. Phylogenetic tree based on single nucleotide polymorphism (SNP) analysis of whole-genome sequencing (WGS) data from 32 vancomycin-resistant enterococcus faecium (VRE) isolates. Four outbreak clones were identified: ST 203 (isolates differing by 0–4 SNPs), ST 1839 (isolates differing by 0–4 SNPs), ST 80 (isolates differing by 5 SNP), and ST 612 (unique clone).

Figure 3. Drawing of ward 12 at the Surgical Unit at Vrinnevi Hospital, Norrköping, Sweden, where the clustering of vancomycin-resistant enterococcus faecium (VRE) took place. Letters (A–D) indicate the number of available bed spaces per room. Rooms where patients culture-positive for the ST 203 clone had been placed are marked with dotted squares. The numbers of admitted VRE cases and VRE-positive environmental samples per room are shown in the inserted table.

Evaluation of cleaning procedures

Of the 242 environmental samples collected before the improved cleaning in ward 12, 10 (4,1%) were positive for the ST 203 outbreak clone, which shows that the VRE acquisition was not sufficiently reduced. Nine samples were found either in the single-bed room (room 14), where the index case had recently been placed (40%), or in the 4-bed room (room 9), previously occupied by VRE-positive patients (50 %) (Figure 3). The culture-positive sites included general surfaces in patient rooms and bathrooms, such as the toilet handle, seat, and roll holder, as well as the bed rail, mattress, armchair, and the NEWS (National Early Warning System) tool. Most positive samples originated from the bathroom. After implementing 3 approved quality-controlled discharge cleanings at the Surgical Unit, none of the collected environmental samples (n = 104) in ward 12 showed growth of VRE. The direct feedback on whether approved ATP values had been achieved after each cleaning resulted in higher quality of cleaning, which was apparently sufficient in reducing the VRE acquisition. The cleaning routine was implemented across all hospital units in Östergötland County with VRE-positive patients.

Discussion

In the present study, the first VRE outbreak in Östergötland County, Sweden, at the Surgical Unit of Vrinnevi Hospital in Norrköping, was described. Active rapid screening was initiated and provided important real-time data to direct actions to reduce the outbreak. By using PCR directly from fecal swabs, the delay inherent to culture-based methods, often requiring several days for bacterial growth and identification, was effectively eliminated and allowed for much faster detection of carriers. Early detection of VRE carriers is crucial in limiting transmission and plays a key role in effective outbreak management as described in other studies. Reference Cheah, Cheng, Spelman, Nation, Kong and McBryde7,Reference Holzknecht, Hansen, Nielsen, Kailow and Jarlov8,Reference Zabicka, Strzelecki and Wozniak13

This is one of the first studies to use WGS during an outbreak rather than retrospectively to quickly determine whether isolates are related. The use of WGS and subsequent MLST analysis was crucial in clarifying the outbreak dynamics. It enabled rapid assessment of the genetic relatedness between VRE isolates and allowed assignment to specific clusters. Among the 22 patients involved, the main outbreak clone (ST203) was identified in ward 12 at the Surgical Unit, distinct from the three other clones detected during the same period. Studies have shown an increase in VRE colonization during hospital stay, and that patients sharing a room and a toilet with a VRE carrier had a high acquisition rate. Reference Reyes, Bardossy and Zervos1,Reference Ajao, Harris and Roghmann14 This aligns with our findings of high proportions of VRE cases and positive environmental samples in ward 12, particularly in room 9, suggesting that patient proximity and shared facilities facilitated transmission.

Although lack of compliance to basic hygiene routines is one of the main reasons why hospital outbreaks occur, previous studies have highlighted rapid identification of cases and adequate cleaning as important factors in controlling VRE outbreaks. Reference Eichel, Boutin and Frank15 The cleaning routine implemented in the Surgical Unit, comprising 3 approved discharge cleanings per room after a VRE-positive patient, proved effective and resulted in a drastic reduction in both VRE cases and environmental contamination. This aligns with a previous study showing that repeated cleaning improves VRE decontamination. Reference Byers, Durbin, Simonton, Anglim, Adal and Farr16 ATP measurement serves as an effective quantitative method to assess cleaning quality in healthcare settings, aiding in the detection of residual contamination after disinfection Reference Kenters, Huijskens, de Wit, van Rosmalen and Voss17,Reference Niephaus, Parohl, Heiligtag, Reuter, Hackler and Popp18 A major challenge during the outbreak was confusion over whether healthcare workers in the unit or the cleaning organization were responsible for cleaning certain environmental surfaces and medical devices. Additionally, executors lacked knowledge about proper cleaning frequency and methods, potentially leading to inadequate disinfection. Similar concerns have been reported in other studies. Reference Goodman, Platt, Bass, Onderdonk, Yokoe and Huang19Reference Dancer and Kramer21

Antibiotic exposure, especially to substances with a high likelihood of disturbing the gut flora, has been identified as a risk factor for both the acquisition and transmission of VRE, and consequently, antibiotic stewardship is of importance both to prevent and confine an outbreak of VRE. Reference Donskey, Chowdhry and Hecker22Reference Hughes, Sullivan and Marshall24 The present outbreak, although the main efforts focused on hygiene measures, highlighted that antibiotic prescribing related to urological surgery needed improvement, and measures were implemented accordingly.

A limitation of this study is that multiple interventions were implemented simultaneously, making it difficult to determine the relative contribution and effectiveness of each measure in controlling the outbreak.

Conclusions

An outbreak of VRE involving 22 patients and 4 distinct clones was confirmed with WGS. An empowered task force, active rapid screening, timely WGS typing, and quality-controlled cleaning were effective. To prevent further outbreaks, antibiotic stewardship was strengthened, a 3-step quality-controlled discharge cleaning routine maintained, and use of multiple-bed rooms restricted.

Acknowledgements

We thank everyone involved for their excellent collaboration, which contributed to containing the outbreak.

Financial support

None reported.

Competing interests

All authors report no conflicts of interest relevant to this article.

References

Reyes, K, Bardossy, AC, Zervos, M. Vancomycin-resistant enterococci: epidemiology, infection prevention, and control. Infect Dis Clin North Am 2016;30:953965.10.1016/j.idc.2016.07.009CrossRefGoogle ScholarPubMed
Levitus, M, Rewane, A, Perera, TB. Vancomycin-Resistant Enterococci. Treasure Island (FL): StatPearls; 2021.Google Scholar
Fiore, E, Van Tyne, D, Gilmore, MS. Pathogenicity of enterococci. Microbiol Spectr 2019;7:eGPP3-0053-2018. https://doi.org/10.1128/microbiolspec.gpp3-0053-2018 CrossRefGoogle ScholarPubMed
Faron, ML, Ledeboer, NA, Buchan, BW. Resistance mechanisms, epidemiology, and approaches to screening for vancomycin-resistant enterococcus in the health care setting. J Clin Microbiol 2016;54:24362447.10.1128/JCM.00211-16CrossRefGoogle ScholarPubMed
Contreras, GA, Munita, JM, Arias, CA. Novel strategies for the management of vancomycin-resistant enterococcal infections. Curr Infect Dis Rep 2019;21:22.10.1007/s11908-019-0680-yCrossRefGoogle ScholarPubMed
Collins, CD, Kollmeyer, S, Scheidel, C et al. Impact of a mortality prediction rule for organizing and guiding antimicrobial stewardship program activities. Open Forum Infect Dis 2021;8:ofab056.10.1093/ofid/ofab056CrossRefGoogle ScholarPubMed
Cheah, ALY, Cheng, AC, Spelman, D, Nation, RL, Kong, DCM, McBryde, ES. Mathematical modelling of vancomycin-resistant enterococci transmission during passive surveillance and active surveillance with contact isolation highlights the need to identify and address the source of acquisition. BMC Infect Dis 2018;18:511.10.1186/s12879-018-3388-yCrossRefGoogle ScholarPubMed
Holzknecht, BJ, Hansen, DS, Nielsen, L, Kailow, A, Jarlov, JO. Screening for vancomycin-resistant enterococci with Xpert(R) vanA/vanB: diagnostic accuracy and impact on infection control decision making. New Microbes New Infect 2017;16:5459.10.1016/j.nmni.2016.12.020CrossRefGoogle Scholar
Soderblom, T, Aspevall, O, Erntell, M, et al. Alarming spread of vancomycin resistant enterococci in Sweden since 2007. Euro Surveill 2010;15:19620.10.2807/ese.15.29.19620-enCrossRefGoogle ScholarPubMed
Jolley, KA, Bray, JE, Maiden, MCJ. Open-access bacterial population genomics: BIGSdb software, the PubMLST.org website and their applications. Wellcome Open Res 2018;3:124.10.12688/wellcomeopenres.14826.1CrossRefGoogle ScholarPubMed
Homan, WL, Tribe, D, Poznanski, S, et al. Multilocus sequence typing scheme for enterococcus faecium. J Clin Microbiol 2002;40:19631971.10.1128/JCM.40.6.1963-1971.2002CrossRefGoogle ScholarPubMed
Schurch, AC, Arredondo-Alonso, S, Willems, RJL, Goering, RV. Whole genome sequencing options for bacterial strain typing and epidemiologic analysis based on single nucleotide polymorphism versus gene-by-gene-based approaches. Clin Microbiol Infect 2018;24:350354.10.1016/j.cmi.2017.12.016CrossRefGoogle ScholarPubMed
Zabicka, D, Strzelecki, J, Wozniak, A et al. Efficiency of the cepheid xpert vanA/vanB assay for screening of colonization with vancomycin-resistant enterococci during hospital outbreak. Antonie Van Leeuwenhoek 2012;101:671675.10.1007/s10482-011-9681-zCrossRefGoogle ScholarPubMed
Ajao, AO, Harris, AD, Roghmann, MC et al. Systematic review of measurement and adjustment for colonization pressure in studies of methicillin-resistant staphylococcus aureus, vancomycin-resistant enterococci, and clostridium difficile acquisition. Infect Control Hosp Epidemiol 2011;32:481489.10.1086/659403CrossRefGoogle ScholarPubMed
Eichel, VM, Boutin, S, Frank, U, et al. Impact of discontinuing contact precautions and enforcement of basic hygiene measures on nosocomial vancomycin-resistant enterococcus faecium transmission. J Hosp Infect 2022;121:120127.10.1016/j.jhin.2021.11.020CrossRefGoogle ScholarPubMed
Byers, KE, Durbin, LJ, Simonton, BM, Anglim, AM, Adal, KA, Farr, BM. Disinfection of hospital rooms contaminated with vancomycin-resistant enterococcus faecium. Infect Control Hosp Epidemiol 1998;19:261264.Google ScholarPubMed
Kenters, N, Huijskens, EGW, de Wit, SCJ, van Rosmalen, J, Voss, A. Effectiveness of cleaning-disinfection wipes and sprays against multidrug-resistant outbreak strains. Am J Infect Control 2017;45:e69e73.10.1016/j.ajic.2017.04.290CrossRefGoogle ScholarPubMed
Niephaus, V, Parohl, N, Heiligtag, S, Reuter, H, Hackler, R, Popp, W. Can the adenosine triphosphate (ATP) bioluminescence assay be used as an indicator for hospital cleaning? - a pilot study. GMS Hyg Infect Control 2024;19:Doc07.Google Scholar
Goodman, ER, Platt, R, Bass, R, Onderdonk, AB, Yokoe, DS, Huang, SS. Impact of an environmental cleaning intervention on the presence of methicillin-resistant staphylococcus aureus and vancomycin-resistant enterococci on surfaces in intensive care unit rooms. Infect Control Hosp Epidemiol 2008;29:593599.10.1086/588566CrossRefGoogle ScholarPubMed
Mitchell, BG, White, N, Farrington, A, et al. Changes in knowledge and attitudes of hospital environmental services staff: the researching effective approaches to cleaning in hospitals (REACH) study. Am J Infect Control 2018;46:980985.10.1016/j.ajic.2018.02.003CrossRefGoogle ScholarPubMed
Dancer, SJ, Kramer, A. Four steps to clean hospitals: LOOK, PLAN, CLEAN and DRY. J Hosp Infect 2019;103:e1e8.10.1016/j.jhin.2018.12.015CrossRefGoogle Scholar
Donskey, CJ, Chowdhry, TK, Hecker, MT, et al. Effect of antibiotic therapy on the density of vancomycin-resistant enterococci in the stool of colonized patients. N Engl J Med 2000;343:19251932.CrossRefGoogle Scholar
Webb, BJ, Majers, J, Healy, R, et al. Antimicrobial stewardship in a hematological Malignancy unit: carbapenem reduction and decreased vancomycin-resistant enterococcus infection. Clin Infect Dis 2020;71:960967.10.1093/cid/ciz900CrossRefGoogle Scholar
Hughes, A, Sullivan, SG, Marshall, C. Factors associated with vanA VRE acquisition in cardiothoracic surgery patients during an acute outbreak. Infect Dis Health 2021;6:258264.10.1016/j.idh.2021.05.003CrossRefGoogle Scholar
Figure 0

Figure 1. Prevalence of patients positive for vancomycin-resistant enterococcus faecium (VRE) at Vrinnevi Hospital, Norrköping, Sweden, 2015—August 2021. Bars indicate the total number of VRE-positive cases identified each year. Outbreak-associated cases (ST 203) and unrelated cases are shown in distinct colors. Infection control measures implemented during the outbreak are indicated on the time line.

Figure 1

Figure 2. Phylogenetic tree based on single nucleotide polymorphism (SNP) analysis of whole-genome sequencing (WGS) data from 32 vancomycin-resistant enterococcus faecium (VRE) isolates. Four outbreak clones were identified: ST 203 (isolates differing by 0–4 SNPs), ST 1839 (isolates differing by 0–4 SNPs), ST 80 (isolates differing by 5 SNP), and ST 612 (unique clone).

Figure 2

Figure 3. Drawing of ward 12 at the Surgical Unit at Vrinnevi Hospital, Norrköping, Sweden, where the clustering of vancomycin-resistant enterococcus faecium (VRE) took place. Letters (A–D) indicate the number of available bed spaces per room. Rooms where patients culture-positive for the ST 203 clone had been placed are marked with dotted squares. The numbers of admitted VRE cases and VRE-positive environmental samples per room are shown in the inserted table.